Sarah Gheuens Stock Option Exercise at Agios Pharmaceuticals

Sarah Gheuens, an officer at Agios Pharmaceuticals, Inc., has exercised stock options for 3,302 shares of common stock on October 27, 2025. The stock options were originally granted on February 25, 2025. The transaction was executed at a market value of $145,027.80, with the shares being sold through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing also confirms that there were no other securities sold by Gheuens in the past three months.